This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Earnings Watch: Stocks Under $5

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

1. Peregrine Pharmaceuticals (PPHM - Get Report)

Company Profile: Peregrine Pharmaceuticals is a clinical-stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and viral infections.

Earnings Reporting Date: July 14 (confirmed)

Current Share Price: $1.97

2011 Share Price Performance: -14%

Analyst Ratings: Peregrine nets a "buy" rating from Roth Capital Partners and McNicoll Lewis. Both research shops have a $10 price target on the stock.

What To Watch For: In Peregrine's fiscal third quarter, revenue plunged to $2.9 million from $9.9 million in the same quarter a year prior. Peregrine blamed the decrease on both a reduction in government contract revenue as well as lower contract manufacturing revenue due to the level and timing of services provided to third-party clients of its Avid Bioservices subsidiary. In addition to watching revenue, investors should be on the lookout for any update to Phase II survival data for its treatment of non-small cell lung cancer.

-- Written by Robert Holmes in Boston.

>To contact the writer of this article, click here: Robert Holmes.

>To follow Robert Holmes on Twitter, go to http://twitter.com/RobTheStreet.

>To submit a news tip, send an email to: tips@thestreet.com.
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
6 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
IBCA $10.78 1.99%
SVBL $0.08 0.00%
PRXI $2.03 0.00%
JOEZ $0.17 0.00%
MSN $1.30 0.00%

Markets

Chart of I:DJI
DOW 16,374.76 +23.38 0.14%
S&P 500 1,951.13 +2.27 0.12%
NASDAQ 4,733.4970 -16.4820 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs